Endo Int'l (ENDP) Tops Q1 EPS by 4c, Guides FY Well Below Consensus
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
CP, RUSHA, SEIC, More
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $963.5 million versus the consensus estimate of $955.91 million.
GUIDANCE:
Endo Int'l sees FY2016 EPS of $4.50-$4.80, versus the consensus of $5.69. Endo Int'l sees FY2016 revenue of $3.87-4.03 million, versus the consensus of $4.29 million.
For earnings history and earnings-related data on Endo Int'l (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Peapack-Gladstone Financial (PGC) Misses Q1 EPS by 3c
- Greene County Bancorp, Inc. (GCBC) Reports Q3 EPS of $0.34
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!